Understanding the clinical pharmacology of antiviral therapy is pivotal to designing optimal treatment and prevention strategies. Drug exposure is significantly influenced by drug interactions, medication taking behavior, and patients’ physiologic and genetic characteristics. These factors are central to determining therapeutic efficacy, failure or toxicity. Despite great progress, many pharmacologic challenges still exist.
The International Workshop on Clinical Pharmacology of Antiviral Therapy 2018 will again provide a platformfor discussions of current topics fundamental to the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance, and regulatory considerations.
The Clinical Pharmacology workshop is a unique platform where industry, academic and governmental pharmacologists and regulatory scientists share and discuss the latest developments and challenges in clinical pharmacology. Improved knowledge on drug efficacy/toxicity and potential drug interactions enables clinicians to further optimize antiviral treatment and prevention interventions.
The 2018 edition is tentatively scheduled for May 2018, Washington DC, USA.
We look forward to welcoming you to another exciting edition.
On behalf of the Organizing Committee,
Terry Blaschke and Courtney Fletcher